Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register BLIS Technologies for InfoPages here.
BLIS Technologies - Latest News [Page 1]
Blis confirms Asia-Pacific and Africa distribution agreement
Friday, 7 September 2018, 1:51 pm | BLIS Technologies
Blis Technologies Limited today confirmed it has entered into a distribution agreement with iNova Pharmaceuticals (Singapore) Pte Ltd for the distribution of BLIS branded products. iNova Pharmaceuticals is a multinational pharmaceutical and consumer health ... More >>
Study results show probiotic helps prevent rheumatic fever
Monday, 13 February 2017, 1:04 pm | BLIS Technologies
As the Government launches a new rheumatic fever awareness campaign this week, results from a recent European clinical trial show that the daily use of a Kiwi-developed oral probiotic, BLIS K12 TM, is associated with a significant and ongoing reduction ... More >>
New study shows benefits of Kiwi-developed probiotic
Tuesday, 24 January 2017, 1:58 pm | BLIS Technologies
A recent study by Italy’s pre-eminent researcher into probiotics has concluded that a Kiwi-developed oral probiotic, BLIS K12 TM, is associated with a significant reduction in ear and throat infections (acute otitis media and streptococcal pharyngitis) ... More >>
European study shows benefits of Kiwi-developed probiotic
Monday, 23 January 2017, 3:41 pm | BLIS Technologies
A recent study by Italy’s pre-eminent researcher into probiotics has concluded that a Kiwi-developed oral probiotic, BLIS K12 TM, is associated with a significant reduction in ear and throat infections (acute otitis media and streptococcal pharyngitis) ... More >>
Blis Gets Key ‘Letter of No Objection’ From US FDA
Friday, 29 January 2016, 12:57 pm | BLIS Technologies
Blis Technologies Gets Key ‘Letter of No Objection’ From US Food and Drug Administration for Ingredient BLIS K12 More >>
Doubled Revenue for BLIS Technologies
Monday, 25 May 2015, 11:50 am | BLIS Technologies
Following the release of a year-end result that shows a doubling of revenue to $2.631 million, and a loss slightly less than the previous year at $1.373 million, BLIS Technologies chief executive Barry Richardson said sales growth is set to continue. More >>
New Offshore Marketing Configuration for BLIS Technologies
Thursday, 19 March 2015, 2:10 pm | BLIS Technologies
NZX-listed BLIS Technologies Limited has announced a reconfiguration of its offshore marketing arrangements in line with its strategy of broadening its product offering beyond ingredients and into finished products of BLIS K12TM and BLIS M18TM oral health ... More >>
Former Comvita CEO joins BLIS Technologies Board
Thursday, 5 March 2015, 11:26 am | BLIS Technologies
When Graeme Boyd was approached to join the board of probiotic health product manufacturer BLIS Technologies he had no trouble understanding exactly what they were doing and what the next steps should be. More >>
Toddlers Now Get Benefits Of Probiotics
Wednesday, 23 July 2014, 5:49 pm | BLIS Technologies
Dunedin-based BLIS Technologies has launched a new probiotic powder suitable for children as young as six months old. The powder, part of the BLIS K12™ product range, is aimed at introducing healthy bacteria into the mouth and throats of young ... More >>
BLIS Technologies Strategy Endorsed
Friday, 30 August 2013, 2:50 pm | BLIS Technologies
BLIS Technologies (“BLT” or the “Company”) shareholders ratified the capital raising initiatives supporting its business development strategy at the Annual Shareholders Meeting in Dunedin today. More >>
BLIS Technologies help fight rheumatic fever with probiotics
Thursday, 29 August 2013, 1:45 pm | BLIS Technologies
Dunedin company BLIS Technologies Ltd have partnered with the Eastern Bay of Plenty Primary Health Alliance, Kawerau Rheumatic Fever Prevention Program. The company has donated 200 bottles of its BLIS K12 Throat Guard Daily probiotics to aid children ... More >>
BLIS Technologies Annual Report
Tuesday, 28 May 2013, 1:12 pm | BLIS Technologies
The Directors of BLIS Technologies (“BLT”) advise that the Group recorded a net deficit of $1,856k for the March 2013 financial year (2012:$1,759k). The result was in line with the revised guidance provided in February 2013 and reflected a disappointing ... More >>
FSANZ clears the way for BLIS M18 probiotic use in foods
Friday, 18 January 2013, 12:59 pm | BLIS Technologies
BLIS Technologies Ltd (NZX:BLT) is pleased to advise that it has received a written acknowledgement from Food Standards Australia New Zealand (‘FSANZ’) that its new probiotic, BLIS M18™ is not considered by the authority to be a Novel Food ... More >>
A new 2013 research report extends the benefit of BLIS K12™
Friday, 11 January 2013, 3:12 pm | BLIS Technologies
From: BLIS Technologies Ltd (NZX:BLT) MediaPak: National Pak Date: Friday, 11 Dec 2013 Release: Immediate A new 2013 research report extends the benefit of BLIS K12™ probiotic More >>
New research looks at "dog breath
Monday, 15 October 2012, 10:08 am | BLIS Technologies
BLIS Technologies Ltd (NZX:BLT) announces the successful completion of the first phase in a research programme, which focuses on preventing bad breath in dogs. According to the programme leader at BLIS Technologies, Dr John Hale the BLIS K12™ probiotic, ... More >>
BLIS joins with Salvation Army against childhood disease
Thursday, 11 October 2012, 5:16 pm | BLIS Technologies
Dunedin based, BLIS Technologies Ltd (NZX: BLT) and The Salvation Army have joined forces to fight the battle against tonsillitis and rheumatic fever, which generally affects children and has been reaching levels within New Zealand only seen in the ... More >>
BLIS Technologies Targets New Probiotic Against Tooth Decay
Friday, 5 October 2012, 10:55 am | BLIS Technologies
BLIS Technologies Ltd (NZX:BLT) announces that it is introducing a new BLIS probiotic into the New Zealand retail market called BLIS M18™. This new BLIS probiotic has been shown in clinical trials to inhibit bacteria associated with tooth decay and ... More >>
New Study confirms effectiveness of BLIS K12™
Thursday, 13 September 2012, 12:27 pm | BLIS Technologies
BLIS Technologies Ltd (NZX:BLT) announces the recent independent publication by a Swiss research team at the University of Basel, evaluating the oral cavity probiotic, BLIS K12™ for its ability to inhibit bacteria responsible for the severe bad breath ... More >>
BLIS Technologies Improves second half-year performance
Tuesday, 22 May 2012, 10:45 am | BLIS Technologies
Dunedin based biotechnology company, BLIS Technologies Ltd (NZX: BLT) recently reported to its shareholders the results for its financial year, ending 31st March 2012. More >>
New Research extends the Benefit of BLIS K12
Wednesday, 18 April 2012, 9:26 am | BLIS Technologies
A recent study by Canadian and Japanese researchers shows new benefits for the BLIS K12 probiotic. BLIS Technologies Ltd (NZX: BLT) has reported that this new research, published in the international journal Applied and Environmental Microbiology, further ... More >>
